| |
|
|
|
|
Nanogen, Inc.(NGEN)
|
|
|
|
|
|
|
|
|
| 123Jump Rating: |
|
Underwriters: |
Morgan Stanley Dean Witter
|
| |
|
|
Lehman Brothers
|
| Status: |
|
|
SBC Warburg Dillon Read Inc.
|
| |
| Address: |
10398 Pacific Center Court
|
FiledDate: |
|
| |
|
|
|
| |
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
(619) 546-7700 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
|
Shares Offered (Millions): |
3,900,000 |
| |
|
|
|
| Websites: |
|
Shares Outstanding (Millions): |
18,242,000 |
| |
|
|
|
| Management: |
Howard C. Birndorf, CEO/CFO
|
IPO Date: |
|
| |
Tina S. Nova, Ph.D., COO
|
|
|
| |
W.J. Kitchen, Sc.D., SVP
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
|
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
90 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
Human Genome Science
|
S-1 Forms: |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 1994
|
0.00 |
2410 |
-2410 |
0.00 |
-2376 |
0.00 |
| 1995
|
318 |
5002 |
-4684 |
0.00 |
-4588 |
0.00 |
| 1996
|
1644 |
9358 |
-7714 |
0.00 |
-7778 |
0.00 |
| 1997
|
3366 |
15556 |
-12190 |
0.00 |
-11215 |
-1.1 |
|
|
|
|
|
|
|
| |
|
| |
|
|
